However, accumulating evidence has shown that the expression of RhoGDI1 and RhoGDI2 is upregulated or downregulated in different human cancers and closely associated with cancer malignancy, as shown in Table 2, indicating that the functions of RhoGDIs in cancer progression are complex and controversial. The gene discussed is ARHGDIA; the disease is cancer.